Previous 10 | Next 10 |
Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...
Exscientia Plc (EXAI) is expected to report $-0.42 for Q3 2023
Company to host conference call and webcast on November 9, 2023, at 1:30 p.m. GMT / 8:30 a.m. EST Exscientia plc (Nasdaq: EXAI) will report financial results for the third quarter ended September 30, 2023, on Thursday, November 9, 2023, before the open of U.S. markets. The Company will ...
Renowned technology champion to strengthen company’s development of precision medicine and clinical innovation platforms Exscientia plc (Nasdaq: EXAI) today announced the appointment of Parker Moss as Executive Vice President, Corporate Development, effective January, 2024. In th...
— Demonstrated preclinical efficacy of LSD1 inhibitor in primary AML samples — — Initial data supporting combination potential of LSD1 inhibitor with AML standard of care therapies — — Tumour growth inhibition through MALT1 in monotherapy and com...
2023-10-11 10:00:00 ET More on Health Care Select Sector SPDR BofA reports 10th consecutive week of equity inflows Citi turns cautious on pharmaceuticals and biotech Seeking Alpha’s Quant Rating on Health Care Select Sector SPDR For further details see...
Concentrating rapidly emerging pipeline on most differentiated, highest value oncology targets, including CDK7 and LSD1 programmes Partnering or discontinuing internal development of programmes outside of core focus, including A 2A and select discovery targets Strategy will su...
2023-09-20 14:02:43 ET Summary Exscientia plc has partnered with Merck KGaA for AI-powered drug discovery in complex disease segments, solidifying its industry positioning. AI is gaining traction in the healthcare industry, with projections estimating the AI drug discovery market ...
2023-09-20 12:27:59 ET DENVER, Colo., Sept 20, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Genius Group (NYSEAMERICAN:GNS), Steelcase (NYSE:SCS), Fresh Tracks Therapeutics (NASDAQ:FRTX), Exscie...
2023-09-20 10:11:33 ET DENVER, Colo., Sept 20, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Genius Group (NYSEAMERICAN:GNS), Steelcase (NYSE:SCS), Fresh Tracks Therapeutics (NASDAQ:FRTX), Exscientia (N...
News, Short Squeeze, Breakout and More Instantly...
2024-07-27 08:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Maximises upside potential of precision-designed GTAEXS617 with purchase of rights from GT Apeiron Monotherapy dose escalation data readout for ELUCIDATE Phase 1/2 trial on track for second half of 2024 Combination dose escalation study starting with HR+/HER2- breast cancer to com...
— State-of-the-art platform, built using Amazon Web Services technologies, integrates generative AI drug design and robotic lab automation to further accelerate Exscientia’s ability to deliver high quality drug candidates at faster speed and lower cost — Exscientia ...